Xizang Haisco Pharmaceutical Group Co Ltd (002653) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥39.68 Million ≈ $5.81 Million USD) by net assets (CN¥4.23 Billion ≈ $618.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Xizang Haisco Pharmaceutical Group Co Lt defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Xizang Haisco Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Xizang Haisco Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Xizang Haisco Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xizang Haisco Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shenzhen Transsion Holdings Co Ltd
SHG:688036
0.157x
Waaree Energies Limited
NSE:WAAREEENER
0.038x
Puig Brands SA
MC:PUIG
0.241x
Maxscend Microelectronics Co Ltd
SHE:300782
-0.021x
Tempus AI, Inc. Class A Common Stock
NASDAQ:TEM
-0.075x
Masimo Corporation
NASDAQ:MASI
0.084x
FSN E-Commerce Ventures Limited
NSE:NYKAA
0.086x
PayPay Corporation American Depository Shares
NASDAQ:PAYP
1.056x

Annual Cash Flow Conversion Efficiency for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Xizang Haisco Pharmaceutical Group Co Lt (002653) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥4.29 Billion
≈ $627.44 Million
CN¥786.00 Million
≈ $115.02 Million
0.183x +74.26%
2024-12-31 CN¥4.20 Billion
≈ $614.92 Million
CN¥442.05 Million
≈ $64.69 Million
0.105x -2.42%
2023-12-31 CN¥4.17 Billion
≈ $610.28 Million
CN¥449.58 Million
≈ $65.79 Million
0.108x +257.25%
2022-12-31 CN¥3.13 Billion
≈ $458.49 Million
CN¥94.55 Million
≈ $13.84 Million
0.030x +146.13%
2021-12-31 CN¥2.92 Billion
≈ $427.32 Million
CN¥35.80 Million
≈ $5.24 Million
0.012x -83.03%
2020-12-31 CN¥2.85 Billion
≈ $417.74 Million
CN¥206.21 Million
≈ $30.17 Million
0.072x -77.54%
2019-12-31 CN¥2.38 Billion
≈ $347.78 Million
CN¥764.26 Million
≈ $111.84 Million
0.322x +35.70%
2018-12-31 CN¥1.99 Billion
≈ $291.83 Million
CN¥472.61 Million
≈ $69.16 Million
0.237x +19.17%
2017-12-31 CN¥1.97 Billion
≈ $288.32 Million
CN¥391.81 Million
≈ $57.33 Million
0.199x +9.11%
2016-12-31 CN¥2.25 Billion
≈ $328.53 Million
CN¥409.20 Million
≈ $59.88 Million
0.182x -11.28%
2015-12-31 CN¥2.16 Billion
≈ $315.58 Million
CN¥443.03 Million
≈ $64.83 Million
0.205x -13.86%
2014-12-31 CN¥2.11 Billion
≈ $308.37 Million
CN¥502.57 Million
≈ $73.54 Million
0.238x -19.15%
2013-12-31 CN¥1.93 Billion
≈ $281.97 Million
CN¥568.41 Million
≈ $83.18 Million
0.295x +8.40%
2012-12-31 CN¥1.71 Billion
≈ $249.91 Million
CN¥464.75 Million
≈ $68.01 Million
0.272x -19.89%
2011-12-31 CN¥767.76 Million
≈ $112.35 Million
CN¥260.79 Million
≈ $38.16 Million
0.340x -58.11%
2010-12-31 CN¥453.09 Million
≈ $66.30 Million
CN¥367.38 Million
≈ $53.76 Million
0.811x -70.23%
2009-12-31 CN¥135.17 Million
≈ $19.78 Million
CN¥368.21 Million
≈ $53.88 Million
2.724x +519.97%
2008-12-31 CN¥214.95 Million
≈ $31.45 Million
CN¥94.45 Million
≈ $13.82 Million
0.439x --

About Xizang Haisco Pharmaceutical Group Co Ltd

SHE:002653 China Biotechnology
Market Cap
$9.36 Billion
CN¥63.95 Billion CNY
Market Cap Rank
#2380 Global
#296 in China
Share Price
CN¥57.10
Change (1 day)
-1.57%
52-Week Range
CN¥42.19 - CN¥61.47
All Time High
CN¥61.47
About

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research c… Read more